Asia Pacific Overall Healthcare Outlook 2010

2010 Asia Pacific Healthcare Outlook

Analysis of Best Opportunities

P3B5-54

April 2010

2P3B5-54

Disclaimer

• Frost & Sullivan takes no responsibility for the incorrect information supplied to us by manufacturers or users.

• Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation.

• Frost & Sullivan Research Services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that Frost & Sullivan Research Services are for customers’ internal use and not for general publication or disclosure to third parties.

• No part of this Research Service may be given, lent, resold, or disclosed to non-customers without written permission.

• Furthermore, no part may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the permission of the publisher.

• For information regarding permission, write to:

Frost & Sullivan GIC Malaysia Sdn. Bhd.

Suite E-08-15, Block E

Plaza Mont’ Kiara

2 Jalan Kiara, Mont’ Kiara

50480 Kuala Lumpur.

© 2010 Frost & Sullivan. All rights reserved. This document contains highly confidential information and is the sole property of Frost & Sullivan. No part of it may be circulated, quoted, copied or otherwise reproduced without the written approval of Frost & Sullivan.

3P3B5-54

Certification

• We hereby certify that the views expressed in this research service accurately reflect our views based on primary

and secondary research with industry participants, industry experts, end users, regulatory organizations, financial

and investment community, and other related sources.

• In addition to the above, our robust in-house forecast & benchmarking models along with the Frost & Sullivan

Decision Support Databases have been instrumental in the completion and publishing of this research service.

• We also certify that no part of our analyst compensation was, is or will be, directly or indirectly, related to the

specific recommendations or views expressed in this research service.

4P3B5-54

TABLE OF CONTENT

1. Overview of Healthcare Market : Key Takeaways

• Setting the Scene: Outlook for Healthcare Industry from 2010-12

• Global vs. APAC: The New Frontier

2. In-depth Sectoral Analysis, APAC and S Korea

• APAC Pharmaceuticals & Biotechnology Market

• APAC Medical Devices Market

• APAC Clinical Diagnostics Market

• APAC Lifesciences and Health IT Market

• APAC Medical Imaging Market

3. Summary : Best Opportunity Analysis, APAC

• Where to place your bets in APAC: 2010- 2012

4. Decision Support Database

• Total Health Expenditure

• Private Health Expenditure

• Government Health Expenditure

• Percent Healthcare Expenditure in GDP

• Population Aged Above 65

5. About Frost & Sullivan

5

Overview of Healthcare Market : Key Takeaways

6P3B5-54

Setting the Scene Outlook for Healthcare Industry from 2010-12

Source: Frost & Sullivan

Global Healthcare Market : 2009

• US and Europe were impacted in a major way by global crisis

• Asia also slowed down but not as much as the West

• Valuations were low and M&A was high, many smaller Biotech companies struggled

• Major organizational restructuring occurred, along with portfolios being reassessed

Global Healthcare Market : 2010-12

• Recovery of the markets to a large extent with strong growth in Asia

• Start of major patent expiries

• M&A activity down in the West but could be important in Asia, restructuring will continue

• Asia becoming increasingly important as a market and outsourcing hub

• 5Ps to drive market: Preventive, Preemptive, Personalized, Predictive, Personal Responsibility

7P3B5-54

Global vs. APAC: The New FrontierBy 2012 APAC expected to be close to 27% of global market

247 277 311 348

815 880 906 934

0

200

400

600

800

1000

1200

1400

1600

1800

2009 2010 2011 2012

10621157

12181282

23.9%23.9%

27.2%27.2%

23.2%23.2%

26.4%26.4%

CAGR12.2%CAGR12.2%

CAGR6.47%CAGR6.47%

Global & APAC Healthcare Revenues US$ Bn, 2009-2012

• By 2015 APAC could represent ~40% of global market!

Rest of the World

APAC

Note: All figures are rounded; the base year is 2009. Source: Frost and SullivanNote: All figures are rounded; the base year is 2009. Source: Frost and Sullivan

8P3B5-54

Asia is however transitioningMoving toward a Multi–Polar World Order

Asia Pacific Market : 2009

• Slowing down of GDP in mature markets – Japan and Australia took a big hit

• Global consolidation left a difficult mess for integration on a local level – job losses and portfolio realignment

• Price cutting and playing the margins game

• The bubble burst for Medical Tourism

• Asia started to set up infrastructure for offshoring and outsourcing for US/EU companies

Asia Pacific Market : 2012

• A shift in the center of the world economically and strategically to Asia

• Asia to move from export led development to consumption led growth

• APAC the fastest growing pharma market and API production hub

• Increased government attention to primary and community based healthcare.

• Focus on building infrastructure and education: government role will be higher

• Increased use of mobile technology in healthcare service delivery

Source: Frost & Sullivan

9

In-depth Sectoral Analysis, APAC

10P3B5-54

APAC Pharmaceuticals & Biotechnology MarketEarlier diagnosis improves disease management and length of therapy


Market Drivers

Market Restraints

Long term use of multiple and specialized drugs for the ageing population

Government support for generics and biosimilars

Enhanced diagnosis and management in oncology, cardiovascular, pain etc

Unresolved political and regulations issues Quality concern of generics & counterfeits

Government tenders favour local manufacturers

180 203.5 230 260

570 621.5 636 649

0100200300400500600700800900

100011001200

2009 2010 2011 2012

Rest of the World

APAC

24.6% 28.5%

CAGR6.6 %

CAGR6.6 %

CAGR12.9 %CAGR12.9 %

Pharma & Biotech Revenues, US$ Bn, 2009-2012

APAC Share

750825 866 909

11P3B5-54

APAC Medical Devices MarketTransition to a mindset of monitoring


46.5 51.3 56.5 62.3

156.5 163.7 171 178.4

0

50

100

150

200

250

300

350

2009 2010 2011 2012

Rest of the World

APAC

203 215 227.5 240.7

23.8%23.8%

25.8%25.8%

Market Drivers

Market Restraints

•Safety, accuracy, efficiency, cost

•Silver industry devices

•Convergence of devices and pharma products

•Regulatory and reimbursement hurdles

•Lack of sufficient distribution networks

•Inadequate training/certification for allied staff

Medical Devices Revenues, US$ Bn, 2009-2012

APAC Share

CAGR5.8%

CAGR5.8%

CAGR10.2%CAGR10.2%

12P3B5-54


APAC Clinical Diagnostics Market Shift in business model from instrumentation to service revenues

6.9 7.3 7.8 8.5

31.7 33.6 35.6 37.5

0

10

20

30

40

50

60

2009 2010 2011 2012

Rest of the World

APAC

38.640.9

43.446

17.8%17.8%

18.5%18.5%

Market Drivers

Market Restraints

Lab automation

Home care monitoring

Emphasis on early detection

High cost of genomics and proteomics tests

Mutually exclusive target customers

Reimbursement issues

Clinical Diagnostics Revenues, US$ Bn, 2009-2012

APAC Share

CAGR7.3%

CAGR7.3%

CAGR6%

CAGR6%

13P3B5-54


*Healthcare IT includes: Software, Hardware, IT services and Lifesciences IT

APAC Lifesciences and Health IT Market*Interoperability challenges hinder adoption

7.1 7.9 8.8 9.8

43.5 46.7 49.6 52.7

0

10

20

30

40

50

60

70

80

2009 2010 2011 2012

Rest of the World

APAC

14.5%14.5%

15.7%15.7%

Market Drivers

Market Restraints

Operational efficiency Strong and sustained demand for healthcare services

Consumer demand for quality and access to information

Interoperability

Integration

Lack of skilled resources

Lifesciences & Healthcare IT, US$ Bn, 2009-2012

CAGR7%

CAGR7%

CAGR11.3%CAGR11.3%

APAC Share

50.654.6

58.4 62.5

14P3B5-54

APAC Medical Imaging MarketTurnkey projects drive double digit growth in Asia


6 6.8 7.7 8.6

13.8 14.2 14.6 15

0

5

10

15

20

25

30

35

40

2009 2010 2011 2012

Rest of the World

APAC

19.8 21 22.3 23.6

32.4%32.4%

36.4%36.4%

Market Drivers

Market Restraints

Rise in turnkey projects

Increasing corporate wellness programs

Integration of Imaging with information systems

New customer sets to be addressed

Price erosion

CAGR6%

CAGR6%

CAGR12.7%CAGR12.7%

Imaging Market Revenues, US$ Bn, 2009-2012

APAC Share

15

Summary : Best Opportunity Analysis APAC

16P3B5-54

Where to place your bets in APAC: 2010- 2012

Time

Gro

wth Molecular

Diagnostics

Silver IndustryEquipment

POCT

Vaccines/Biologics

Endoscopy

EMR/EHR

WellnessProducts

Oncology

Value basedImaging

INNOVATIONTRIGGER

SUPERGROWTH

NORMALISATION LEADERSHIP

IndiaChina

S.Korea

SingaporeMalaysia

Vietnam

HealthcareServices

Source: Frost & Sullivan.

17

Decision Support Database

• Total Health Expenditure

• Private Health Expenditure

• Government Health Expenditure

• Percent Healthcare Expenditure in GDP

• Population Aged Above 65

18P3B5-54

Decision Support Databases

Decision Support DatabaseTable Total Healthcare Expenditure (Bn USD)

Region / Country 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012CAGR %

(2005 - 2012)North America

Canada 73.0 87.8 101.2 116.9 129.5 138.3 147.0 155.2 163.0 169.8 175.9 6.00United States 1,559.0 1,678.9 1,804.7 1,936.6 2,077.5 2,232.9 2,399.2 2,573.3 2,753.9 2,944.2 3,146.3 7.18

TOTAL 1,632.0 1,766.6 1,905.9 2,053.5 2,207.0 2,371.2 2,546.3 2,728.6 2,916.8 3,114.0 3,322.1 7.11

Latin America

Argentina 11.5 14.7 17.3 20.9 23.3 25.7 27.8 29.9 31.8 33.7 35.5 7.85Brazil 40.7 45.8 55.6 74.0 78.8 83.8 90.0 97.0 104.9 113.7 123.6 7.60Chile 3.8 4.4 5.8 7.0 8.0 9.0 9.9 10.8 11.8 12.8 13.8 10.17Mexico 59.6 58.5 62.2 72.3 78.8 84.7 91.0 97.5 104.0 110.4 116.7 7.08Peru 2.4 2.7 3.1 3.6 3.9 4.2 4.5 4.9 5.2 5.6 5.9 7.46Venezuela 4.7 4.7 6.2 7.2 8.2 9.3 10.5 11.8 13.4 15.3 17.7 13.82

TOTAL 122.7 130.8 150.2 185.0 200.9 216.7 233.8 251.8 271.1 291.5 313.2 7.81

Asia - Pacific

Australia 39.4 51.0 62.4 69.9 74.7 79.9 85.1 90.4 95.9 101.4 107.1 6.29China 71.9 84.3 98.7 116.0 134.3 152.9 172.5 193.7 217.0 242.5 270.7 12.87Hong Kong 9.4 9.5 10.0 10.9 11.9 13.0 14.1 15.5 16.9 18.5 20.3 9.25India 27.5 36.1 41.9 48.5 54.0 59.8 66.1 72.8 80.0 87.5 95.5 10.16Indonesia 6.4 8.0 8.8 9.3 10.6 12.0 13.5 15.3 17.3 19.6 22.2 13.15Japan 315.4 339.5 374.9 379.7 394.0 406.6 414.7 424.9 437.0 451.7 467.5 3.02Malaysia 3.6 4.0 4.6 5.2 5.9 6.7 7.6 8.6 9.6 10.8 11.9 12.66New Zealand 5.1 6.7 8.5 9.4 10.4 11.4 12.3 13.1 13.8 14.4 14.9 6.77Philippines 2.3 2.3 2.5 2.8 3.2 3.6 4.0 4.4 4.9 5.5 6.0 11.45Singapore 3.7 4.0 4.3 4.6 5.0 5.3 5.7 6.2 6.6 7.1 7.6 7.46South Korea 25.3 30.1 33.9 39.3 43.3 47.7 52.2 56.7 61.2 66.0 70.9 8.81Taiwan 16.9 17.8 19.2 21.0 22.8 24.7 26.5 28.2 30.0 31.8 33.6 6.92Thailand 7.8 8.5 9.6 10.7 11.9 13.3 14.8 16.6 18.7 21.1 23.8 12.18

TOTAL 534.6 601.6 679.2 727.3 781.9 836.8 889.1 946.3 1,008.8 1,077.7 1,152.0 6.79

19P3B5-54

Decision Support Databases (Contd…)



(2005 - 2012)Western Europe

Austria 15.3 19.2 22.1 23.1 24.0 24.8 25.7 26.5 27.2 27.9 28.5 3.04Belgium 22.6 29.3 34.0 35.8 37.4 38.9 40.3 41.6 42.9 44.1 45.3 3.40Denmark 15.2 19.2 22.2 23.4 24.4 25.4 26.4 27.4 28.3 29.3 30.3 3.78Finland 9.5 11.8 13.6 14.4 15.1 16.0 16.9 17.7 18.5 19.3 20.1 4.90France 139.0 176.8 205.6 217.9 228.6 239.0 249.3 259.1 268.4 277.8 286.6 3.99Germany 211.1 258.9 294.6 305.9 314.9 323.7 332.6 341.2 349.3 358.1 366.6 2.62Greece 13.0 17.2 19.6 22.3 23.9 25.4 27.0 28.6 30.2 31.8 33.4 5.99Iceland 0.8 1.1 1.3 1.6 1.8 2.0 2.1 2.3 2.4 2.6 2.7 7.80Ireland 9.7 12.8 15.4 16.3 17.9 19.3 20.8 22.3 23.8 25.3 26.8 7.43Italy 99.6 122.3 139.7 143.4 149.1 154.0 159.0 163.8 168.1 172.0 175.4 2.92Luxembourg 1.5 1.9 2.3 2.5 2.7 2.8 2.9 3.0 3.2 3.3 3.4 4.14Netherlands 39.0 50.4 58.1 60.6 63.8 66.2 68.7 71.1 73.3 75.5 77.6 3.59Norway 18.3 22.7 26.1 30.4 32.5 34.7 36.9 39.3 41.4 43.4 45.5 5.94Portugal 11.3 14.3 16.5 17.3 18.2 19.1 20.0 20.9 21.9 22.8 23.8 4.60Spain 49.7 65.0 77.1 88.4 94.4 100.2 106.1 112.1 117.6 123.2 128.1 5.45Sweden 22.2 28.4 33.5 34.1 35.6 37.1 39.2 41.4 43.9 46.6 49.7 5.53Switzerland 29.7 37.0 41.5 43.1 45.7 48.4 51.1 53.8 56.5 59.3 62.2 5.39United Kingdom 121.0 141.5 170.0 180.7 191.9 203.3 214.8 227.0 238.7 250.4 262.6 5.49

TOTAL 828.6 1,029.6 1,193.2 1,261.1 1,321.7 1,380.3 1,439.8 1,499.0 1,555.5 1,612.8 1,668.5 4.08

Eastern Europe

Czech Republic 5.0 6.8 7.5 9.0 9.9 10.8 11.7 12.7 13.6 14.5 15.5 8.03Hungary 4.9 6.9 8.6 9.6 10.8 11.8 12.9 13.9 14.9 15.9 16.8 8.23Poland 12.5 13.6 15.2 17.9 19.7 21.2 22.9 24.7 26.5 28.2 29.8 7.59Russia 21.3 26.2 32.6 38.2 43.7 48.8 53.9 58.7 63.4 67.9 72.2 9.51Turkey 11.6 15.8 19.7 26.0 28.6 31.5 34.0 36.4 39.0 41.2 43.3 7.55

TOTAL 55.4 69.3 83.6 100.8 112.6 124.1 135.3 146.4 157.3 167.7 177.6 8.43

20P3B5-54




(2005 - 2012)Middle East & Africa

Egypt 4.0 3.5 3.7 4.4 5.5 6.5 7.5 8.5 9.7 11.0 12.4 16.03Israel 9.0 9.7 10.4 11.0 11.8 12.5 13.2 14.2 15.3 16.5 17.8 7.05Saudi Arabia 7.9 8.8 9.6 10.4 11.2 11.8 12.4 13.0 13.6 14.2 14.8 5.13South Africa 9.1 13.6 20.0 19.6 20.5 21.6 22.7 23.9 25.2 26.7 28.4 5.50

TOTAL 30.0 35.5 43.6 45.4 49.0 52.4 55.8 59.6 63.7 68.3 73.4 7.11

WORLD TOTAL 3,203.3 3,633.5 4,055.6 4,373.0 4,673.2 4,981.4 5,300.0 5,631.6 5,973.3 6,331.9 6,706.8 6.30

Note: All figures are rounded; the base year is 2005. Source: Frost & SullivanDefinition

Note1. Figures for 2005 are Frost & Sullivan estimates

The above figures indicate health care expenditure

Source: Frost & SullivanSource: Frost & Sullivan

21P3B5-54


Decision Support DatabaseTable Private Healthcare Expenditure (Bn USD)



Canada 22.2 26.2 30.5 35.6 39.7 42.6 45.5 48.3 50.8 53.1 55.2 6.48United States 841.0 913.2 980.5 1,045.3 1,078.0 1,155.7 1,240.9 1,330.0 1,421.0 1,517.4 1,614.5 6.41

TOTAL 863.2 939.4 1,011.0 1,080.8 1,117.7 1,198.3 1,286.4 1,378.2 1,471.9 1,570.5 1,669.7 6.41

Latin America


TOTAL 66.4 71.0 81.4 100.5 109.8 118.6 128.0 137.9 148.4 159.5 171.3 7.92

Asia - Pacific


TOTAL 177.0 204.7 235.1 264.9 293.2 320.2 345.1 372.0 401.5 435.7 472.6 8.62

22P3B5-54






TOTAL 208.8 262.0 302.3 319.3 331.4 345.0 358.5 371.7 382.7 394.2 404.7 3.45

Eastern Europe


TOTAL 18.8 23.5 28.7 34.8 39.0 43.2 47.4 51.4 55.4 59.2 62.9 8.84

23P3B5-54






TOTAL 14.0 16.7 22.0 23.1 25.2 27.3 29.3 31.6 34.1 36.9 40.0 8.17

WORLD TOTAL 1,348.2 1,517.3 1,680.4 1,823.3 1,916.3 2,052.5 2,194.7 2,342.7 2,493.8 2,655.8 2,821.2 6.43



Figures in the table represents private health expenditure


24P3B5-54


Decision Support DatabaseTable Government Healthcare Expenditure (Bn USD)



Canada 50.8 61.6 70.7 81.4 89.8 95.7 101.5 107.0 112.1 116.7 120.7 5.79United States 718.0 765.7 824.2 891.3 999.5 1,077.2 1,158.4 1,243.4 1,332.9 1,426.8 1,531.8 8.04

TOTAL 768.8 827.3 895.0 972.7 1,089.3 1,172.9 1,259.9 1,350.3 1,445.0 1,543.5 1,652.5 7.87

Latin America


TOTAL 56.3 59.8 68.8 84.5 91.1 98.1 105.8 113.9 122.7 132.0 141.9 7.69

Asia - Pacific


TOTAL 357.5 396.9 444.1 462.4 488.8 516.7 543.9 574.3 607.3 642.0 679.4 5.65

25P3B5-54






TOTAL 619.8 767.6 890.9 941.8 990.3 1,035.3 1,081.3 1,127.3 1,172.8 1,218.6 1,263.7 4.29

Eastern Europe


TOTAL 36.6 45.9 54.9 66.0 73.7 80.9 88.0 95.1 102.0 108.5 114.7 8.21

26P3B5-54






TOTAL 16.0 18.8 21.6 22.3 23.7 25.1 26.5 28.1 29.7 31.5 33.3 5.93

WORLD TOTAL 1,855.1 2,116.2 2,375.2 2,549.6 2,756.9 2,929.0 3,105.3 3,288.9 3,479.5 3,676.2 3,885.5 6.20



The above figures indicate health care expenditure by government


27P3B5-54

Decision Support DatabaseTable Percent Healthcare Expenditure in GDP

Region / Country 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012North America

Canada 9.9 10.1 10.2 10.3 10.4 10.7 11.0 11.2 11.4 11.5 11.6United States 14.9 15.3 15.4 15.2 15.4 15.6 15.9 16.3 16.6 17.0 17.4

TOTAL 14.6 14.9 15.0 14.8 15.0 15.2 15.5 15.8 16.2 16.5 16.9

Latin America

Argentina 11.3 11.3 11.3 11.4 11.5 11.7 11.8 11.9 12.0 12.2 12.4Brazil 9.1 9.1 9.2 9.3 9.3 9.3 9.3 9.3 9.4 9.5 9.6Chile 5.8 6.0 6.1 6.4 6.4 6.5 6.5 6.5 6.6 6.7 6.7Mexico 9.2 9.4 9.4 9.4 9.6 9.8 9.9 10.1 10.3 10.5 10.7Peru 4.4 4.5 4.5 4.6 4.7 4.8 4.9 5.0 5.2 5.3 5.5Venezuela 4.9 5.5 5.5 5.6 5.7 5.7 5.8 5.8 5.9 5.9 5.9

TOTAL 8.7 8.8 8.9 9.0 9.0 9.1 9.2 9.2 9.3 9.4 9.5

Asia - Pacific

Australia 9.6 9.7 9.9 10.5 10.7 10.9 11.0 11.1 11.2 11.4 11.7China 5.7 6.0 6.0 6.1 6.4 6.6 6.8 7.0 7.1 7.3 7.5Hong Kong 5.8 6.1 6.2 6.2 6.3 6.6 6.8 6.9 7.1 7.3 7.5India 6.1 6.1 6.4 6.4 6.5 6.6 6.7 6.7 6.8 6.9 6.9Indonesia 3.7 3.4 3.4 3.5 3.5 3.5 3.6 3.7 3.8 3.9 4.0Japan 6.8 6.9 7.0 7.0 7.4 7.9 7.7 7.7 7.8 7.8 7.8Malaysia 3.8 3.9 3.9 4.0 4.1 4.3 4.4 4.6 4.7 4.8 5.0New Zealand 8.7 8.6 8.7 9.0 9.2 9.3 9.5 9.7 9.8 9.9 9.9Philippines 2.9 2.9 2.9 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.1Singapore 3.8 3.9 3.9 3.9 3.9 4.0 4.0 4.0 4.0 4.1 4.2South Korea 4.9 4.9 5.0 5.0 5.1 5.1 5.2 5.2 5.2 5.3 5.3Taiwan 6.0 6.0 6.1 6.1 6.1 6.1 6.2 6.2 6.3 6.3 6.3Thailand 5.8 5.9 5.9 6.1 6.2 6.3 6.4 6.6 6.8 7.1 7.5

TOTAL 6.4 6.5 6.6 6.6 6.8 7.1 7.0 7.1 7.2 7.2 7.3


28P3B5-54



Region / Country 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012

Western Europe

Austria 7.5 7.5 7.6 7.6 7.6 7.6 7.6 7.6 7.6 7.7 7.7Belgium 9.1 9.6 9.6 9.7 9.8 9.9 9.9 10.0 10.1 10.2 10.3Denmark 8.8 9.1 9.2 9.1 9.2 9.3 9.4 9.5 9.5 9.5 9.5Finland 7.2 7.3 7.3 7.5 7.6 7.6 7.7 7.7 7.7 7.8 7.8France 9.7 9.8 10.0 10.3 10.5 10.7 10.8 10.9 11.0 11.1 11.3Germany 10.6 10.6 10.7 10.9 11.1 11.2 11.3 11.4 11.5 11.7 11.9Greece 9.8 9.9 9.9 10.0 10.1 10.2 10.2 10.3 10.2 10.3 10.3Iceland 9.9 10.5 10.6 10.6 10.9 11.1 11.3 11.5 11.7 11.9 12.0Ireland 8.0 8.4 8.5 8.6 8.8 9.0 9.2 9.3 9.5 9.7 9.9Italy 8.4 8.3 8.3 8.4 8.4 8.4 8.4 8.5 8.5 8.5 8.5Luxembourg 6.9 6.9 7.0 7.1 7.2 7.3 7.4 7.5 7.6 7.7 7.7Netherlands 9.3 9.8 9.8 10.6 10.9 11.0 11.1 11.2 11.3 11.4 11.6Norway 9.6 10.3 10.4 10.4 10.6 10.8 11.0 11.2 11.4 11.6 11.8Portugal 9.3 9.7 9.9 10.1 10.2 10.3 10.5 10.6 10.7 10.9 11.0Spain 7.6 7.7 7.8 7.9 7.9 8.0 8.1 8.2 8.2 8.3 8.4Sweden 9.2 9.4 9.6 9.7 9.9 10.0 10.1 10.2 10.3 10.4 10.6Switzerland 11.1 11.5 11.5 11.7 11.8 11.9 12.0 12.1 12.3 12.4 12.6United Kingdom 7.7 7.8 8.0 8.2 8.4 8.6 8.8 9.0 9.2 9.3 9.5

TOTAL 9.0 9.1 9.2 9.3 9.5 9.6 9.7 9.8 9.9 10.0 10.1

Eastern Europe

Czech Republic 7.2 7.5 7.5 7.6 7.6 7.7 7.7 7.7 7.9 8.0 8.2Hungary 7.8 8.4 8.6 8.8 8.9 9.0 9.1 9.2 9.3 9.4 9.5Poland 5.9 5.9 6.0 6.0 6.0 6.1 6.3 6.4 6.5 6.6 6.6Russia 6.1 6.1 6.2 6.2 6.2 6.3 6.3 6.4 6.4 6.5 6.6Turkey 6.5 6.6 6.7 6.8 6.8 6.8 6.8 6.9 7.0 7.1 7.2

TOTAL 6.6 6.6 6.6 6.7 6.7 6.8 6.8 6.9 6.9 7.0 7.0

29P3B5-54



Region / Country 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012

Middle East & Africa

Egypt 4.9 5.0 5.0 5.1 5.1 5.2 5.2 5.2 5.2 5.3 5.3Israel 8.7 8.8 8.8 9.0 9.1 9.1 9.2 9.3 9.4 9.5 9.6Saudi Arabia 4.3 4.3 4.4 4.4 4.4 4.5 4.5 4.5 4.6 4.6 4.7South Africa 8.7 8.2 9.4 8.2 8.1 8.2 8.2 8.2 8.2 8.2 8.2

TOTAL 6.1 6.1 6.1 6.2 6.2 6.2 6.2 6.3 6.2 6.3 6.3

WORLD TOTAL 10.2 10.2 10.3 10.3 10.4 10.6 10.7 10.9 11.0 11.2 11.4


Note1. Regional and World total are calculated using weighted average of countries in the region and are not the simple average.

The above figures represent Healthcare Expenditure as percentage of Gross Domestic Product.


30P3B5-54


Decision Support DatabaseTable Population 65 Plus (Mn)



Canada 4.1 4.2 4.2 4.3 4.4 4.5 4.6 4.7 4.9 5.0 5.2 2.66United States 35.6 35.9 36.3 36.7 37.2 37.9 38.7 39.5 40.2 41.1 42.6 2.14

TOTAL 39.7 40.1 40.5 41.0 41.6 42.4 43.3 44.2 45.1 46.1 47.7 2.19

Latin America


TOTAL 22.9 23.7 24.5 25.3 26.1 27.0 27.9 28.8 29.8 30.8 31.9 3.40

Asia - Pacific


TOTAL 193.8 199.2 204.3 209.6 215.4 221.4 227.1 233.2 239.4 246.0 254.0 2.79

31P3B5-54




(2005 - 2012)

Western Europe


TOTAL 65.4 66.4 67.4 68.4 69.3 70.0 70.8 71.7 72.4 73.3 74.6 1.24

Eastern Europe

Czech Republic 1.4 1.4 1.4 1.5 1.5 1.5 1.5 1.6 1.6 1.7 1.7 2.64Hungary 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.6 1.6 1.6 1.6 0.86Poland 4.9 5.0 5.0 5.1 5.1 5.1 5.2 5.2 5.2 5.3 5.4 0.83Russia 18.8 19.3 19.8 20.3 20.6 20.8 20.4 19.8 19.2 18.8 18.9 (1.38)Turkey 4.2 4.4 4.5 4.7 4.8 4.9 5.1 5.2 5.3 5.5 5.6 2.54

TOTAL 30.8 31.6 32.3 33.0 33.5 33.9 33.7 33.3 32.9 32.8 33.2 (0.14)

32P3B5-54






TOTAL 6.4 6.6 6.7 6.9 7.1 7.4 7.6 7.8 8.0 8.3 8.6 3.09

WORLD TOTAL 358.9 367.4 375.7 384.3 393.1 402.0 410.3 418.9 427.6 437.4 450.1 2.28


The above figures represent total midyear population aged 65 years and above


33P3B5-54

Who is Frost & Sullivan

The Growth Partnership Company

• Founded in 1961, Frost & Sullivan has over 45 years of assisting clients with their decision-making

and growth issues.

• Over 1,700 Growth Consultants and Industry Analysts across 32 global locations

• Over 10,000 clients worldwide - emerging companies, the global 1000 and the investment community

• Developers of the Growth Excellence Matrix – industry leading growth positioning tool for corporate

executives

• Developers of TEAM Methodology, proprietary process to ensure that clients receive a 360o

perspective of technology, markets and growth opportunities

• Three core services: Growth Partnership Services, Growth Consulting and Career Best

Practices

34

About Frost & Sullivan

35P3B5-54

What Makes Us Unique

Exclusively Focused on Growth

Global thought leader exclusively focused on addressing client growth strategies and plans – Team actively engaged in researching and developing of growth models that enable clients to achieve aggressive growth objectives.

Industry Breadth

Cover the broad spectrum of industries and technologies to provide clients with the ability to look outside the box and discover new and innovative ideas.

Global Perspective

32 global offices ensure that clients receive a global coverage/perspective based on regional expertise.

360o Perspective

Proprietary TEAM Methodology integrates all 6 critical research methodologies to significantly enhance the accuracy of decision making and lower the risk of implementing growth strategies.

Growth Monitoring

Continuously monitor changing technology, markets and economics and proactively address clients growth initiatives and position.

Trusted Partner

Working closely with client Growth Teams – helping them generate new growth initiatives and leverage all of Frost & Sullivan assets to accelerate their growth.

36P3B5-54

TEAM Methodology

Frost & Sullivan’s proprietary TEAM methodology, ensures that clients have complete “360 Degree

Perspective” from which to drive decision-making. Technical, Econometric, Application, and Market

information ensures that clients have a comprehensive view of industries, markets and technology.

Technical Real-time intelligence on technology, including emerging technologies, new

R&D breakthroughs, technology forecasting, impact analysis, groundbreaking

research, and licensing opportunities.

Econometric In-depth qualitative and quantitative research focused on timely and critical

global, regional, and country specific trends, including the political,

demographic, and socioeconomic landscapes.

Application Insightful strategies, networking opportunities, and best practices that can be

applied for enhanced market growth; interactions between the client, peers, and

Frost & Sullivan representatives that result in added value and effectiveness.

Market Global and regional market analysis, including drivers and restraints, market

trends, regulatory changes, competitive insights, growth forecasts, industry

challenges, strategic recommendations, and end-user perspectives.

37P3B5-54

Global Perspective

• 1,700 staff across every major market worldwide

• Over 10,000 clients worldwide from emerging to global 1000 companies

Asia Pacific Overall Healthcare Outlook 2010

Health & Medicine

Transcript of Asia Pacific Overall Healthcare Outlook 2010